MyDx Details Mission for Crowdsourcing Data from CannaDx Users
San Diego, CA, October 30, 2015 --(PR.com)-- Daniel Yazbeck, Chairman & CEO of MyDx Inc. (OTCQB: MYDX), creator of MyDx™ (My Diagnostic), the first battery-operated, handheld, chemical analyzer for consumers, announced that the company will leverage its crowdsourced, anonymized user data to support legalization across the U.S.
Yazbeck will discuss MyDx’s mission of crowdsourcing anonymized user data from its CannaDx users, in addition to participating in company pitches with top c-suite executives at the Cannabis Growth Capital Conference, produced by Marijuana Investor Summit, Las Vegas, Nov. 10-11.
“MyDx offers a practical way to conduct a worldwide crowdsourced study of cannabis, and the Cannabis Growth Capital Conference provides a premier platform for sharing MyDx’s vision of transforming an anecdotal industry into actionable cannabis intelligence,” Yazbeck said.
The MyDx Analyzer with the CannaDx sensor offers a comprehensive digital ecosystem of hardware and software that enables users to track, self-quantify and record their reactions (feelings) and ailment relief on a strain-by-strain basis. This data empowers an individual cannabis consumer to find the right strain for a specific condition or certain feeling.
Yazbeck sees tremendous potential in leveraging this kind of data. “When we can take anecdotal data that people are generating globally and digitize it into meaningful scientific data that is easily accessible by manufacturers, distributors, consumers and regulators, I believe we can help the industry legalize faster. MyDx ultimately offers a practical way to conduct a worldwide crowdsourced study of cannabis.”
“MyDx knows that anecdotal data will no longer suffice. It has taken the initiative to use its analyzer to crowdsource the data that the industry needs,” said David Friedman, CEO of MJIC Media.
If CannaDx users take the time to provide detailed feedback on multiple strains of cannabis, MyDx will be able to hit critical mass in its data collection and provide the industry with the intelligence it needs.
To learn more about MyDx’s worldwide crowdsourced study, please visit: www.mjinews.com/mydx-transforms-anecdotal-into-data
To purchase your MyDx Analyzer with CannaDx Sensor, please visit: www.cdxlife.com/cdxshop/
To register for the Cannabis Growth Capital Conference, please visit:
http://lasvegas.marijuanainvestorsummit.com/2015/
About MyDx
MyDx Inc. (OTCQB: MYDX) is a science and technology company based in San Diego, California, whose mission is to help people Trust & Verify™ what they put into their minds and bodies. The Company has developed MyDx™, an affordable portable analyzer that provides real-time chemical analysis and fits in the palm of your hands. MyDx™ leverages over a decade of established electronic nose technology to measure chemicals of interest and has recently launched its first application, CannaDx, and three additional sensors (OrganaDx, AquaDx, and AeroDx) are being developed in its lab that are compatible with the MyDx™ Analyzer and App. For more information, please visit www.cdxlife.com.
About MJIC Media
MJIC Media LLC owns and operates the leading properties in the emerging legal cannabis industry, including the Marijuana Index, which tracks and reports on publicly traded cannabis-related equities; Marijuana Investor News, the premier news agency covering the industry; Marijuana Investor Summit, a premium conference provider and industry educator; and Cannabis Trader, the go-to source for cannabis investment education and stock information.
Safe Harbor Statement
This news release contains statements that involve expectations, plans or intentions (such as those relating to future business or financial results, new features or services, or management strategies) and other factors discussed from time to time in the Company’s Securities and Exchange Commission filings. These statements are forward-looking and are subject to risks and uncertainties, so actual results may vary materially. You can identify these forward-looking statements by words such as “may,” “should,” “expect,” “anticipate,” “believe,” “estimate,” “intend,” “plan” and other similar expressions. Our actual results, such as the Company’s ability to finance, complete and consolidate acquisition of IP, assets and operating companies, could differ materially from those anticipated in these forward-looking statements as a result of certain factors not within the control of the company such as a result of various factors, including future economic, competitive, regulatory, and market conditions. The company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. The company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.
MyDx Company Contact:
Jotti Dhillon
MyDx Inc.
Jotti@cdxlife.com
800-814-4550
Yazbeck will discuss MyDx’s mission of crowdsourcing anonymized user data from its CannaDx users, in addition to participating in company pitches with top c-suite executives at the Cannabis Growth Capital Conference, produced by Marijuana Investor Summit, Las Vegas, Nov. 10-11.
“MyDx offers a practical way to conduct a worldwide crowdsourced study of cannabis, and the Cannabis Growth Capital Conference provides a premier platform for sharing MyDx’s vision of transforming an anecdotal industry into actionable cannabis intelligence,” Yazbeck said.
The MyDx Analyzer with the CannaDx sensor offers a comprehensive digital ecosystem of hardware and software that enables users to track, self-quantify and record their reactions (feelings) and ailment relief on a strain-by-strain basis. This data empowers an individual cannabis consumer to find the right strain for a specific condition or certain feeling.
Yazbeck sees tremendous potential in leveraging this kind of data. “When we can take anecdotal data that people are generating globally and digitize it into meaningful scientific data that is easily accessible by manufacturers, distributors, consumers and regulators, I believe we can help the industry legalize faster. MyDx ultimately offers a practical way to conduct a worldwide crowdsourced study of cannabis.”
“MyDx knows that anecdotal data will no longer suffice. It has taken the initiative to use its analyzer to crowdsource the data that the industry needs,” said David Friedman, CEO of MJIC Media.
If CannaDx users take the time to provide detailed feedback on multiple strains of cannabis, MyDx will be able to hit critical mass in its data collection and provide the industry with the intelligence it needs.
To learn more about MyDx’s worldwide crowdsourced study, please visit: www.mjinews.com/mydx-transforms-anecdotal-into-data
To purchase your MyDx Analyzer with CannaDx Sensor, please visit: www.cdxlife.com/cdxshop/
To register for the Cannabis Growth Capital Conference, please visit:
http://lasvegas.marijuanainvestorsummit.com/2015/
About MyDx
MyDx Inc. (OTCQB: MYDX) is a science and technology company based in San Diego, California, whose mission is to help people Trust & Verify™ what they put into their minds and bodies. The Company has developed MyDx™, an affordable portable analyzer that provides real-time chemical analysis and fits in the palm of your hands. MyDx™ leverages over a decade of established electronic nose technology to measure chemicals of interest and has recently launched its first application, CannaDx, and three additional sensors (OrganaDx, AquaDx, and AeroDx) are being developed in its lab that are compatible with the MyDx™ Analyzer and App. For more information, please visit www.cdxlife.com.
About MJIC Media
MJIC Media LLC owns and operates the leading properties in the emerging legal cannabis industry, including the Marijuana Index, which tracks and reports on publicly traded cannabis-related equities; Marijuana Investor News, the premier news agency covering the industry; Marijuana Investor Summit, a premium conference provider and industry educator; and Cannabis Trader, the go-to source for cannabis investment education and stock information.
Safe Harbor Statement
This news release contains statements that involve expectations, plans or intentions (such as those relating to future business or financial results, new features or services, or management strategies) and other factors discussed from time to time in the Company’s Securities and Exchange Commission filings. These statements are forward-looking and are subject to risks and uncertainties, so actual results may vary materially. You can identify these forward-looking statements by words such as “may,” “should,” “expect,” “anticipate,” “believe,” “estimate,” “intend,” “plan” and other similar expressions. Our actual results, such as the Company’s ability to finance, complete and consolidate acquisition of IP, assets and operating companies, could differ materially from those anticipated in these forward-looking statements as a result of certain factors not within the control of the company such as a result of various factors, including future economic, competitive, regulatory, and market conditions. The company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. The company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.
MyDx Company Contact:
Jotti Dhillon
MyDx Inc.
Jotti@cdxlife.com
800-814-4550
Contact
MJIC Media
Kristin Fox
708-267-2584
marijuanainvestorsummit.com
Kristin Fox
708-267-2584
marijuanainvestorsummit.com
Contact
Categories